Innova Captab Limited (INNOVACAP) Financial History

Name: Innova Captab Limited (INNOVACAP) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Innova Captab Limited (INNOVACAP) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Panchkula, India. Its market capitalization is roughly ₹68 billion. In the fiscal year ended 2026-03-31, INNOVACAP reported ₹16.0B in revenue and ₹1.4B in net income.

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs and pharmaceutical products in India and internationally.

Interactive charts & full statements →

INNOVACAP Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹16.0B	₹12.3B	₹10.8B	₹9.3B
Gross Profit	₹5.2B	₹4.0B	₹3.3B	₹2.2B
Operating Income (EBIT)	₹1.9B	₹1.7B	₹1.4B	₹1.1B
Net Income	₹1.4B	₹1.3B	₹944M	₹680M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

INNOVACAP Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total Revenue	₹4.7B	₹4.5B	₹4.5B	₹3.8B	₹3.5B
Gross Profit	₹1.7B	₹1.5B	₹1.6B	₹1.4B	₹1.3B
Operating Income (EBIT)	₹614M	₹537M	₹580M	₹405M	₹410M
Net Income	₹441M	₹381M	₹422M	₹297M	₹310M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

INNOVACAP Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹114M)	—	—	—	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

INNOVACAP Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹18.4B	₹15.8B	₹13.2B	₹7.0B	—
Total Liabilities	₹7.5B	₹6.2B	₹4.9B	₹4.3B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive INNOVACAP viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

PGHL · Procter & Gamble Health Limited — ₹91 billion
4559 · Zeria Pharmaceutical Co., Ltd. — JPY 89 billion
AARTIPHARM · Aarti Pharmalabs Limited — ₹74 billion
BLISSGVS · Bliss GVS Pharma Limited — ₹73 billion
MOREPENLAB · Morepen Laboratories Limited — ₹66 billion
4569 · KYORIN Pharmaceutical Co., Ltd. — JPY 65 billion
SPARC · Sun Pharma Advanced Research Company Limited — ₹63 billion
4886 · ASKA Pharmaceutical Holdings Co.,Ltd. — JPY 62 billion

← INN All “I” companies INNOVANA →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.